Evolving neoantigen profiles in colorectal cancers with DNA repair defects
Autor: | Livio Trusolino, Federica Di Nicolantonio, Alberto Bardelli, Alice Bartolini, Enzo Medico, Alessandro Magrì, Ludovic Barault, Andrea Bertotti, Nabil Amirouchene-Angelozzi, Annalisa Lorenzato, Carola Negrino, Claudio Isella, Monica Montone, Vito Amodio, Giovanni Germano, Giorgio Corti, Giuseppe Rospo, Luca Novara, Carlotta Cancelliere |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
DNA Repair lcsh:Medicine Colorectal cancer DNA repair Immune response Mutational signature Neoantigen Mice SCID Somatic evolution in cancer Transcriptome Mice 0302 clinical medicine Mutation Rate Mice Inbred NOD Genetics (clinical) Exome sequencing 0303 health sciences integumentary system Phenotype 3. Good health 030220 oncology & carcinogenesis Molecular Medicine Female Colorectal Neoplasms lcsh:QH426-470 Antigen presentation Context (language use) Biology Clonal Evolution 03 medical and health sciences Downregulation and upregulation Antigens Neoplasm Cell Line Tumor Genetics Animals Humans Molecular Biology 030304 developmental biology Research lcsh:R Carcinoma Human genetics digestive system diseases lcsh:Genetics 030104 developmental biology Cancer cell Cancer research |
Zdroj: | Genome Medicine Genome Medicine, Vol 11, Iss 1, Pp 1-22 (2019) |
ISSN: | 1756-994X |
Popis: | BackgroundNeoantigens that arise as a consequence of tumour-specific mutations can be recognized by T lymphocytes leading to effective immune surveillance. In colorectal cancer (CRC) and other tumour types, a high number of neoantigens is associated with patient response to immune therapies. The molecular processes governing the generation of neoantigens and their turnover in cancer cells are poorly understood. We exploited CRC as a model system to understand how alterations in DNA repair pathways modulate neoantigen profiles over time.MethodsWe performed Whole Exome Sequencing (WES) and RNA sequencing (RNAseq) in CRC cell lines,in vitroandvivo, and in CRC patient-derived xenografts (PDXs) to track longitudinally genomic profiles, clonal evolution, mutational signatures and predicted neoantigens.ResultsThe majority of CRC models showed remarkably stable mutational and neoantigen profiles, however those carrying defects in DNA repair genes continuously diversified. Rapidly evolving and evolutionary stable CRCs displayed characteristic genomic signatures, and transcriptional profiles. Downregulation of molecules implicated in antigen presentation occurred selectively in highly mutated and rapidly-evolving CRC.ConclusionsThese results indicate that CRC carrying alterations in DNA repair pathways display dynamic neoantigen patterns that fluctuate over time. We define CRC subsets characterized by slow and fast evolvability and link this phenotype to downregulation of antigen-presenting cellular mechanisms. Longitudinal monitoring of the neoantigen landscape could be relevant in the context of precision medicine. |
Databáze: | OpenAIRE |
Externí odkaz: |